Literature DB >> 32789224

Case Reports Describing Amantadine Intoxication in a Rehabilitation Hospital.

Kenjiro Kunieda1, Takashi Shigematsu1, Ichiro Fujishima1.   

Abstract

BACKGROUND: Amantadine is widely used to improve reduced spontaneity and prevent aspiration pneumonia. There are few reports on cases of amantadine intoxication in the field of rehabilitation. CASES: Case 1 involved an 83-year-old man with a history of a lacunar infarction who was transferred to our rehabilitation hospital after a left femoral neck fracture and a left upper arm fracture. He had mild renal dysfunction. Although he was started on oral amantadine 150 mg/dayto reverse a decline in spontaneity, he could not begin rehabilitation therapy because of hallucinations and myoclonus. Furthermore, he developed aspiration pneumonia as a result of a consciousness disorder. After stopping amantadine, his toxic symptoms disappeared completely. Case 2 involved a 53-year-old man who was transferred to our hospital for rehabilitation after a brain contusion. He was started on oral amantadine 100 mg/day to reverse a decline in spontaneity. After amantadine was increased to 150 mg/day, myoclonus and hallucinations developed. At that time, his renal function was mildly impaired. The concentration of amantadine in his blood serum was found to be 4783 ng/dl. After amantadine was stopped, his spontaneity decline recurred. After restarting amantadine at 50 mg/day, his toxic symptoms did not reappear, and the decline in his spontaneity improved. DISCUSSION: Amantadine is a renally excreted drug that may cause toxic symptoms as a result of decreased renal function. It is necessary to monitor renal function and toxic symptoms when amantadine is administered in rehabilitation hospitals. ©2017 The Japanese Association of Rehabilitation Medicine.

Entities:  

Keywords:  amantadine; rehabilitation; renal failure; toxicity

Year:  2017        PMID: 32789224      PMCID: PMC7365224          DOI: 10.2490/prm.20170017

Source DB:  PubMed          Journal:  Prog Rehabil Med        ISSN: 2432-1354


  10 in total

1.  Amantadine and pneumonia.

Authors:  T Nakagawa; H Wada; K Sekizawa; H Arai; H Sasaki
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

Review 2.  Serotonin toxicity: a short review of the literature and two case reports involving citalopram.

Authors:  G Talarico; G Tosto; S Pietracupa; E Piacentini; M Canevelli; G L Lenzi; G Bruno
Journal:  Neurol Sci       Date:  2011-04-14       Impact factor: 3.307

3.  Acute psychosis after amantadine overdose.

Authors:  E R Snoey; H A Bessen
Journal:  Ann Emerg Med       Date:  1990-06       Impact factor: 5.721

4.  Amantadine toxicity presenting with complex ventricular ectopy and hallucinations.

Authors:  L Pimentel; B Hughes
Journal:  Pediatr Emerg Care       Date:  1991-04       Impact factor: 1.454

5.  Fatal overdose with amantadine.

Authors:  P E Cook; S W Dermer; T McGurk
Journal:  Can J Psychiatry       Date:  1986-11       Impact factor: 4.356

6.  Cardiotoxicity after massive amantadine overdose.

Authors:  Michael Schwartz; Manish Patel; Ziad Kazzi; Brent Morgan
Journal:  J Med Toxicol       Date:  2008-09

7.  Reliability and validity of a tool to measure the severity of dysphagia: the Food Intake LEVEL Scale.

Authors:  Kenjiro Kunieda; Tomohisa Ohno; Ichiro Fujishima; Kyoko Hojo; Tatsuya Morita
Journal:  J Pain Symptom Manage       Date:  2012-11-15       Impact factor: 3.612

8.  Amantadine-induced coma.

Authors:  G J Macchio; V Ito; V Sahgal
Journal:  Arch Phys Med Rehabil       Date:  1993-10       Impact factor: 3.966

9.  Obstructive acute renal failure related to amantadine intoxication.

Authors:  Kentaro Nakai; Kazuhito Takeda; Hiroshi Kimura; Shuhei Miura; Atsuhiro Maeda
Journal:  Am J Emerg Med       Date:  2009-03       Impact factor: 2.469

10.  Unexpected amantadine intoxication in the death of a trauma patient.

Authors:  N J Hartshorne; R C Harruff; B K Logan
Journal:  Am J Forensic Med Pathol       Date:  1995-12       Impact factor: 0.921

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.